{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:05:55Z","timestamp":1758906355925},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T00:00:00Z","timestamp":1265068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s12032-010-9432-4","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T20:22:44Z","timestamp":1265055764000},"page":"237-240","source":"Crossref","is-referenced-by-count":9,"title":["Osteolytic lesions marker in multiple myeloma"],"prefix":"10.1007","volume":"28","author":[{"given":"Irena","family":"Djunic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Elezovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Marinkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Suvajdzic-Vukovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragica","family":"Tomin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gradimir","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Bila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darko","family":"Antic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Vidovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borka","family":"Neskovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragica","family":"Nikolic-Vukosavljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,2]]},"reference":[{"key":"9432_CR1","first-page":"29","volume":"50","author":"RA Kyle","year":"1975","unstructured":"Kyle RA. Multiple myeloma, review of 869 cases. Mayo Clin Proc. 1975;50:29\u201340.","journal-title":"Mayo Clin Proc"},{"key":"9432_CR2","first-page":"567","volume":"89","author":"N Abilgard","year":"2004","unstructured":"Abilgard N, Brixen K, Eriksen EF, Kristensen JE, Nilsen JL, Heickendorff L. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma. Haematologica. 2004;89:567\u201377.","journal-title":"Haematologica"},{"key":"9432_CR3","first-page":"3047","volume":"9","author":"C Jakob","year":"2003","unstructured":"Jakob C, Zavirski I, Heider U, et al. Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography. Clin Cancer Res. 2003;9:3047\u201351.","journal-title":"Clin Cancer Res"},{"key":"9432_CR4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/028418600750063578","volume":"39","author":"MA Dimopoulos","year":"2000","unstructured":"Dimopoulos MA, Moulopoulos LA, Datseris I, et al. Imaging of myeloma bone disease-implications for staging, prognosis and follow-up. Acta Oncol. 2000;39:823\u20137.","journal-title":"Acta Oncol"},{"key":"9432_CR5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1365-2141.1999.01244.x","volume":"104","author":"X Mariette","year":"1999","unstructured":"Mariette X, Zagdanski AM, Guermazi A, et al. Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol. 1999;104:723\u20139.","journal-title":"Br J Haematol"},{"key":"9432_CR6","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.V90.6.2127","volume":"90","author":"LA Moulopoulos","year":"1997","unstructured":"Moulopoulos LA, Dimopoulos MA. Magnetic resonance imging of bone marrow in hematologic malignancis. Blood. 1997;90:2127\u201347.","journal-title":"Blood"},{"key":"9432_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<124::AID-AJH10>3.0.CO;2-6","volume":"64","author":"N Abilgaard","year":"2000","unstructured":"Abilgaard N, Glerup H, Rungby J, et al. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma. Eur J Haematol. 2000;64:124\u20139.","journal-title":"Eur J Haematol"},{"key":"9432_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.2003.04050.x","volume":"120","author":"N Abilgaard","year":"2003","unstructured":"Abilgaard N, Brixen K, Kristensen JE, Eriksen EF, Nielsen JL, Heickendorff L. Comparison of five biochemical markers of bone resorption in multiple myeloma: eleveted pretreatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy. Br J Haem. 2003;120:235\u201342.","journal-title":"Br J Haem"},{"key":"9432_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","volume":"88","author":"R Batallie","year":"1991","unstructured":"Batallie R, Chappard D, Marcelli C, et al. Recruitment of new osteoblasts and osteoclasts is the earliest critical event of pathogenesis of human multiple myeloma. J Clin Invest. 1991;88:62\u20136.","journal-title":"J Clin Invest"},{"key":"9432_CR10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.1990.tb07904.x","volume":"76","author":"R Batallie","year":"1990","unstructured":"Batallie R, Chappard D, Marcelli C, et al. Osteoblast stimulation in multiple myeloma lacking lytic bone lesions. Br J Haematol. 1990;76:484\u20137.","journal-title":"Br J Haematol"},{"key":"9432_CR11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajh.20794","volume":"82","author":"O Dizdar","year":"2007","unstructured":"Dizdar O, Barista I, Umut K, et al. Biochemical markers of bone turnover in diagnosis of myeloma bone disease. Am J Haemat. 2007;82:185\u201391.","journal-title":"Am J Haemat"},{"key":"9432_CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2141.1997.8672495.x","volume":"96","author":"N Abilgaard","year":"1997","unstructured":"Abilgaard N, Bentzen S, Nielsen JL, Heickendorff L. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Br J Haem. 1997;96:103\u201310.","journal-title":"Br J Haem"},{"key":"9432_CR13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0009-9120(97)00113-6","volume":"30","author":"RH Christenson","year":"1997","unstructured":"Christenson RH. Biochemical markers of bone metabolism: an overview. Clin Biochem. 1997;30:573\u201393.","journal-title":"Clin Biochem"},{"key":"9432_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1034\/j.1600-0609.2002.00505.x","volume":"69","author":"C Jakob","year":"2002","unstructured":"Jakob C, Zavrski I, Heider U, et al. Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (Ntx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma. Eur J Haematol. 2002;69:37\u201342.","journal-title":"Eur J Haematol"},{"issue":"5","key":"9432_CR15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0609.1999.tb01906.x","volume":"62","author":"K Carlson","year":"1999","unstructured":"Carlson K, Larsson A, Simonsson B, Turesson I, Westin J, Ljunghall S. Evaluation of bone disease in multiple myeloma: a comparison between the resorption markers urinary deoxypyridinoline\/creatinine (DPD) and serum ICTP, and an evaluation of the DPD\/osteocalcin and ICTP\/osteocalcin rations. Eur J Haematol. 1999;62(5):300\u20136.","journal-title":"Eur J Haematol"},{"issue":"4","key":"9432_CR16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/clinchem\/39.4.635","volume":"39","author":"J Risteli","year":"1993","unstructured":"Risteli J, Elomas I, Nieml S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone degradation. Clin Chem. 1993;39(4):635\u201340.","journal-title":"Clin Chem"},{"issue":"2","key":"9432_CR17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bjc.1992.266","volume":"66","author":"I Elmoaa","year":"1992","unstructured":"Elmoaa I, Virkkunen P, Risteli L, Risteli J. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer. 1992;66(2):337\u201341.","journal-title":"Br J Cancer"},{"key":"9432_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2141.2000.01960.x","volume":"109","author":"R Fonseca","year":"2000","unstructured":"Fonseca R, Trendle MC, Leong T, et al. Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients. Br J Haematol. 2000;109:24\u20139.","journal-title":"Br J Haematol"},{"key":"9432_CR19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V80.3.733.733","volume":"80","author":"R Batallie","year":"1992","unstructured":"Batallie R, Boccadoro M, Klein B, Durie BG, Pileri A. C-reactive protein and \u03b22-microglobulin produce a simple and powerful myeloma staging sistem. Blood. 1992;80:733\u20137.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-010-9432-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9432-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T06:52:45Z","timestamp":1590562365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-010-9432-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9432"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9432-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,2]]}}}